MicroRNA23a and MicroRNA23b deregulation derepresses SF-1 and upregulates estrogen signaling in ovarian endometriosis

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages 1575-1582

  Shen, Licong ^a   Yang, Shiyuan ^a   Huang, Wei ^a   Xu, Wenming ^b   Wang, Qiushi ^a   Song, Yong ^a   Liu, Ying ^b  

^a SICHUAN UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN; LUCIFERASE; MICRORNA; MICRORNA 23A; MICRORNA 23B; PROTEIN NR5A1; STEROIDOGENIC FACTOR 1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BIOINFORMATICS; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYP19A1 GENE; DISEASE FREE INTERVAL; DISEASE SEVERITY; DOWN REGULATION; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CELL; ENZYME ASSAY; FEMALE; GENE; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; NR5A1 GENE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SF1 GENE; SIGNAL TRANSDUCTION; STAR GENE; TISSUE DIFFERENTIATION; UPREGULATION;

ADULT; CELLS, CULTURED; ENDOMETRIOSIS; EPIGENETIC REPRESSION; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MICRORNAS; OVARIAN DISEASES; SIGNAL TRANSDUCTION; STEROIDOGENIC FACTOR 1; STROMAL CELLS; TRANSFECTION; UP-REGULATION; YOUNG ADULT;

EID: 84876267504     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3010     Document Type: Article

References (29)

1. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2003; 83: 149-155.
2. Bulun SE, Cheng YH, Yin P, et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006; 248: 94-103.
3. Bulun SE, Lin Z, Imir G, et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005; 57: 359-383.
4. Michael MD, Kilgore MW, Morohashi KI, Simpson ER. Ad4BP/ SF-1 regulates cyclic AMP-induced transcription from the proximal promoter (PII) of the human aromatase P450 (CYP19) gene in the ovary. J Biol Chem. 1995; 270: 13561-13566.
5. Parker KL, Schimmer BP. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev. 1997; 18: 361-377.
6. Nuclear Receptors Nomenclature Committee A unified nomenclature system for the nuclear receptor superfamily. Cell. 1999; 97: 161-163.
7. Zeitoun K, Takayama K, Michael MD, Bulun SE. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of SF-1 and COUP-TF to the same cis-acting element. Mol Endocrinol. 1999; 13: 239-253.
8. Attar E, Tokunaga H, Imir G, et al. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab. 2009; 94: 623-631.
9. Borghese B, Mondon F, Noël JC, et al. Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Mol Endocrinol. 2008; 22: 2557-2562.
10. Utsunomiya H, Cheng YH, Lin Z, et al. Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. Mol Endocrinol. 2008; 22: 904-914.
11. Bulun SE, Utsunomiya H, Lin Z, et al. Steroidogenic factor-1 and endometriosis. Mol Cell Endocrinol. 2009; 300: 104-108.
12. Xue Q, Lin Z, Yin P, et al. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5'CpG island in endometriosis. J Clin Endocrinol Metab. 2007; 92: 3261-3267.
13. Xue Q, Zhou YF, Zhu SN, Bulun SE. Hypermethylation of the CpG Island spanning from exon II to intron III is associated with steroidogenic factor 1 expression in stromal cells of endometriosis. Reprod Sci. 2011; 18: 1080-1084.
14. Pan Q, Luo X, Toloubeydokhti T, Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod. 2007; 13: 797-806.
15. Ohlsson Teague EM, Van der Hoek KH, et al. Micro RNA-regulated pathways associated with endometriosis. Mol Endocrinol. 2009; 23: 265-275.
16. Filigheddu N, Gregnanin I, Porporato PE, et al. Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis. J Biomed Biotechnol. 2010; 2010: 369549.
17. Ramón LA, Braza-Boïls A, Gilabert-Estellés J, et al. microRNAs expression in endometriosis and their relation to angiogenic factors. Hum Reprod. 2011; 26: 1082-1090.
18. Petracco R, Grechukhina O, Popkhadze S, Massasa E, Zhou Y, Taylor HS. MicroRNA 135 regulates HOXA10 expression in endometriosis. J Clin Endocrinol Metab. 2011; 96: E1925-E1933.
19. Lagos-Quintana M, Rauhut R, Lendeckel W, TuschI T. Identification of novel genes coding for small expressed RNAs. Science. 2001; 294: 853-858.
20. Toloubeydokhti T, Pan Q, Luo X, Bukulmez O, Chegini N. The expression and ovarian steroid regulation of endometrial micro-RNAs. Reprod Sci. 2008; 15: 993-1001.
21. Ryan IP, Schriock ED, Taylor RN. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab. 1994; 78: 642-649.
22. Yamamichi N, Shimomura R, Inada K, et al. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res. 2009; 15: 4009-4016.
23. Attar E, Bulun SE. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update. 2006; 12: 49-56.
24. Teague EM, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update. 2010; 16: 142-165.
25. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996; 81: 174-179.
26. Noble LS, Takayama K, Putman JM, et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab. 1997; 82: 600-606.
27. Tsai SJ, Wu MH, Lin CC, Sun HS, Chan HM. Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab. 2001; 86: 5765-5773.
28. Bulun SE, Yang S, Fang Z, et al. Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol. 2001; 79: 19-25.
29. Tian Y, Kong B, Zhu W, Su S, Kan Y. Expression of steroidogenic factor 1 (SF-1) and steroidogenic acute regulatory protein (StAR) in endometriosis is associated with endometriosis severity. J Int Med Res. 2009; 37: 1389-1395.